Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nalin Gupta

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Cancer Cell|July 10, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain TumorPatrick Sin-Chan, Iqra Mumal, Tannu Suwal, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Neoplasia (New York, N.Y.)|November 6, 2022
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open scienceJena V Lilly, Jo Lynne Rokita, Jennifer L Mason, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Pageof 22